Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial

Faster, Cleaner, Better.

GT Biopharma Inc (GTBP)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]

[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]

[[ session ]] by (Cboe BZX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]

[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]

[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]

Balance Sheet for [[ item.sessionDateDisplayLong ]]

Fiscal Year End Date: 12/31

(Values in U.S. thousands)

	09-2009	06-2009	03-2009	12-2008	09-2008
Assets
Current Assets
Cash & Cash Equivalents	N/A	44	N/A	22	31
Receivables	14	10	4	N/A	226
Inventories	3	3	3	3	63
Other current assets	238	238	250	250	0
TOTAL	$315	$355	$257	$275	$335

Non-Current Assets
PPE Net	N/A	N/A	N/A	N/A	30
Intangibles	267	287	301	315	476
Other Non-Current Assets	7	0	0	0	0
TOTAL	$274	$287	$301	$315	$506

Total Assets	$589	$642	$558	$590	$841

Liabilities
Current Liabilities
Short Term Debt	2,123	2,123	2,123	2,123	2,143
Accounts payable and accrued liabilities	989	957	967	919	959
Accrued Expenses	1,363	1,268	1,170	1,029	1,139
Other current liabilities	532	543	229	174	164
TOTAL	$5,178	$4,963	$4,524	$4,270	$4,405

Non-Current Liabilities
TOTAL	$N/A	$N/A	$N/A	$N/A	$N/A

Total Liabilities	$5,178	$4,963	$4,524	$4,270	$4,405

Shareholders' Equity
Shares Outstanding, K	46,851	46,851	46,851	46,851	46,851
Common Shares	47	47	47	47	47
Retained earnings	-75,763	-75,495	-75,140	-74,854	-74,272
Other shareholders' equity	1	1	1	1	-416
TOTAL	$-4,589	$-4,321	$-3,966	$-3,680	$-3,564

Total Liabilities And Equity	$589	$642	$558	$590	$841